Adequan® i.m. is the only FDA-Approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses. For 30 years, it’s been administered by veterinarians to keep horses' joints moving through every ride, from weekend adventures to elite performances.
Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.